by Clay Adams | Mar 4, 2025 | Press Release
Revenues for fourth quarter increased 24% to $3.9 million. Full year revenues increased by 13% to $13.9 million, a historical high. Net Income in the fourth quarter increased 325% to $245,819 and increased 101% to $8,574 for the full year. Full year non-GAAP EBITDA(1)...
by Clay Adams | Jan 13, 2025 | Press Release
Idaho Falls, Idaho, January 13th, 2025. International Isotopes, Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”), is excited to announce a strategic expansion of its company footprint with the recent purchase of vacant land adjacent to its...
by Clay Adams | Jan 9, 2025 | Press Release
IDAHO FALLS, IDAHO, January 9th, 2025. International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that it has amended and finalized the Asset Purchase Agreement with AMICI, Inc., dated June 16th, 2023. To make...
by Clay Adams | Jan 7, 2025 | Press Release
IDAHO FALLS, Idaho and FÜRSTENFELDBRUCK, Germany, January 7, 2025. International Isotopes, a leading provider of medical isotopes and nuclear medicine solutions, is proud to announce its exclusive partnership with SCINTOMICS Molecular, Applied Theranositcs...
by Clay Adams | Nov 11, 2024 | Press Release
Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the prior year. Theranostics Sales increased 42% compared the Third Quarter in the prior year. The Company reported a net profit of $150,000 for the Third Quarter, an improvement...
by Clay Adams | Sep 4, 2024 | Press Release
IDAHO FALLS, Idaho and MADISON, Wisconsin, September 4th, 2024 — International Isotopes, Inc. (INIS) and Phantech Medical (Phantech) have entered into a joint venture agreement to form PhanQual, which will design, manufacture, and distribute long-lived...
Recent Comments